These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22178041)

  • 1. Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies.
    Wood BJ; Poon RT; Locklin JK; Dreher MR; Ng KK; Eugeni M; Seidel G; Dromi S; Neeman Z; Kolf M; Black CD; Prabhakar R; Libutti SK
    J Vasc Interv Radiol; 2012 Feb; 23(2):248-55.e7. PubMed ID: 22178041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Features of Radiofrequency Ablation with Heat-Deployed Liposomal Doxorubicin in Hepatic Tumors.
    Hong CW; Chow L; Turkbey EB; Lencioni R; Libutti SK; Wood BJ
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):409-16. PubMed ID: 26228246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions.
    Tak WY; Lin SM; Wang Y; Zheng J; Vecchione A; Park SY; Chen MH; Wong S; Xu R; Peng CY; Chiou YY; Huang GT; Cai J; Abdullah BJJ; Lee JS; Lee JY; Choi JY; Gopez-Cervantes J; Sherman M; Finn RS; Omata M; O'Neal M; Makris L; Borys N; Poon R; Lencioni R
    Clin Cancer Res; 2018 Jan; 24(1):73-83. PubMed ID: 29018051
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin.
    Celik H; Wakim P; Pritchard WF; Castro M; Leonard S; Karanian JW; Dewhirst MW; Lencioni R; Wood BJ
    J Vasc Interv Radiol; 2019 Dec; 30(12):1908-1914. PubMed ID: 31409568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermosensitive liposomal doxorubicin plus radiofrequency ablation increased tumor destruction and improved survival in patients with medium and large hepatocellular carcinoma: A randomized, double-blinded, dummy-controlled clinical trial in a single center.
    Yang W; Lee JC; Chen MH; Zhang ZY; Bai XM; Yin SS; Cao K; Wang S; Wu W; Yan K
    J Cancer Res Ther; 2019; 15(4):773-783. PubMed ID: 31436231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Duration of Heating Boosts Local Drug Deposition during Radiofrequency Ablation in Combination with Thermally Sensitive Liposomes (ThermoDox) in a Porcine Model.
    Swenson CE; Haemmerich D; Maul DH; Knox B; Ehrhart N; Reed RA
    PLoS One; 2015; 10(10):e0139752. PubMed ID: 26431204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer.
    Poon RT; Borys N
    Expert Opin Pharmacother; 2009 Feb; 10(2):333-43. PubMed ID: 19236203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lyso-thermosensitive liposomal doxorubicin: an adjuvant to increase the cure rate of radiofrequency ablation in liver cancer.
    Poon RT; Borys N
    Future Oncol; 2011 Aug; 7(8):937-45. PubMed ID: 21823888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer.
    Zagar TM; Vujaskovic Z; Formenti S; Rugo H; Muggia F; O'Connor B; Myerson R; Stauffer P; Hsu IC; Diederich C; Straube W; Boss MK; Boico A; Craciunescu O; Maccarini P; Needham D; Borys N; Blackwell KL; Dewhirst MW
    Int J Hyperthermia; 2014 Aug; 30(5):285-94. PubMed ID: 25144817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer.
    Mikhail AS; Negussie AH; Pritchard WF; Haemmerich D; Woods D; Bakhutashvili I; Esparza-Trujillo J; Brancato SJ; Karanian J; Agarwal PK; Wood BJ
    Int J Hyperthermia; 2017 Nov; 33(7):733-740. PubMed ID: 28540814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial.
    Lyon PC; Gray MD; Mannaris C; Folkes LK; Stratford M; Campo L; Chung DYF; Scott S; Anderson M; Goldin R; Carlisle R; Wu F; Middleton MR; Gleeson FV; Coussios CC
    Lancet Oncol; 2018 Aug; 19(8):1027-1039. PubMed ID: 30001990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination radiofrequency ablation and intravenous radiolabeled liposomal Doxorubicin: imaging and quantification of increased drug delivery to tumors.
    Head HW; Dodd GD; Bao A; Soundararajan A; Garcia-Rojas X; Prihoda TJ; McManus LM; Goins BA; Santoyo CA; Phillips WT
    Radiology; 2010 May; 255(2):405-14. PubMed ID: 20413753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model.
    Soundararajan A; Dodd GD; Bao A; Phillips WT; McManus LM; Prihoda TJ; Goins BA
    Radiology; 2011 Dec; 261(3):813-23. PubMed ID: 22025735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals.
    Ahmed M; Liu Z; Lukyanov AN; Signoretti S; Horkan C; Monsky WL; Torchilin VP; Goldberg SN
    Radiology; 2005 May; 235(2):469-77. PubMed ID: 15858089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model.
    Goldberg SN; Girnan GD; Lukyanov AN; Ahmed M; Monsky WL; Gazelle GS; Huertas JC; Stuart KE; Jacobs T; Torchillin VP; Halpern EF; Kruskal JB
    Radiology; 2002 Mar; 222(3):797-804. PubMed ID: 11867804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant liposomal doxorubicin markedly affects radiofrequency ablation-induced effects on periablational microvasculature.
    Moussa M; Goldberg SN; Tasawwar B; Sawant RR; Levchenko T; Kumar G; Torchilin VP; Ahmed M
    J Vasc Interv Radiol; 2013 Jul; 24(7):1021-33. PubMed ID: 23664809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination radiofrequency thermal ablation and adjuvant IV liposomal doxorubicin increases tissue coagulation and intratumoural drug accumulation.
    Ahmed M; Goldberg SN
    Int J Hyperthermia; 2004 Nov; 20(7):781-802. PubMed ID: 15675672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unresectable lung malignancy: combination therapy with segmental pulmonary arterial chemoembolization with drug-eluting microspheres and radiofrequency ablation in 17 patients.
    Gadaleta CD; Solbiati L; Mattioli V; Rubini G; Fazio V; Goffredo V; Vinciarelli G; Gadaleta-Caldarola G; Canniello E; Armenise F; D'Aluisio L; Gaudiano A; Ranieri G; Goldberg SN
    Radiology; 2013 May; 267(2):627-37. PubMed ID: 23249572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy.
    Goldberg SN; Kamel IR; Kruskal JB; Reynolds K; Monsky WL; Stuart KE; Ahmed M; Raptopoulos V
    AJR Am J Roentgenol; 2002 Jul; 179(1):93-101. PubMed ID: 12076912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.